丹化科技(600844.SH):法院一審判決駁回原告李利偉的訴訟請求
格隆匯11月24日丨丹化科技(600844.SH)公佈,公司於2019年10月22日披露了《訴訟公告》,公司股東兼董事李利偉以董事會會議提供的審議文件與披露的《發行股份購買資產暨關聯交易報告書》個別內容存在不符、董事會表決方式不符合公司《董事會議事規則》、公司干擾董事投票等為由,向丹陽市人民法院提起訴訟,要求法院撤消公司第八屆董事會第二十九次會議決議,並由被告承擔本案訴訟費。
經開庭審理後,公司於2019年11月22日收到法院下達的“(2019)蘇1181民初9851號”《民事判決書》,法院一審判決如下:
駁回原告李利偉的訴訟請求,案件受理費減半收取50元,由原告承擔。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.